School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Department of Rehabilitation Medicine, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China.
BMJ Open. 2022 Aug 4;12(8):e060767. doi: 10.1136/bmjopen-2022-060767.
COVID-19 is a highly infectious disease, characterised by respiratory, physical and psychological dysfunctions. Rehabilitation could effectively alleviate the symptoms and promote recovery of the physical and mental health of patients with COVID-19. Recently, rehabilitation medical institutions have issued clinical practice guidelines (CPGs) and expert consensus statements involving recommendations for rehabilitation assessments and rehabilitation therapies for COVID-19. This systematic review aims to assess the methodological quality and reporting quality of the guidance documents, evaluate the heterogeneity of the recommendations and summarise the recommendations with respect to rehabilitation assessments and rehabilitation therapies for COVID-19 to provide a quick reference for front-line clinicians, therapists and patients as well as reasonable suggestions for future guidelines.
The electronic databases including PubMed, Embase, Chinese Biomedical Literature Database (CBM), Chinese Science and Technology Periodical Database (VIP), Wanfang Database and China National Knowledge Infrastructure (CNKI) and websites of governments or organisations (eg, National Guideline Clearinghouse, Guidelines International Network, National Institute for Health and Clinical Excellence, Scottish Intercollegiate Guidelines Network and WHO) will be searched for eligible CPGs and expert consensus statements from inception to August 2022. CPGs and expert consensus statements published in Chinese or English and presenting recommendations for modern functional rehabilitation techniques and/or traditional Chinese medicine rehabilitation techniques for COVID-19 will be included. Reviews, interpretations, old versions of CPGs and expert consensus statements and those for the management of other diseases during the pandemic will be excluded. Two reviewers will independently review each article, extract data, appraise the methodological quality following the Appraisal of Guidelines for Research & Evaluation II tool and assess the reporting quality with the Reporting Items for Practice Guidelines in Healthcare statement. The Measurement Scale of Rate of Agreement will be used to evaluate the heterogeneity of the recommendations in different CPGs and expert consensus statements. Agreement between reviewers will be calculated using the intraclass correlation coefficient. We will also summarise the recommendations for rehabilitation in patients with COVID-19. The results will be narratively described and presented as tables or figures.
Ethics approval is not needed for this systematic review because information from published documents will be used. The findings will be submitted for publication in a peer-reviewed journal and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
CRD42020190761.
COVID-19 是一种高度传染性疾病，其特征为呼吸、身体和心理功能障碍。康复治疗可有效缓解 COVID-19 患者的症状并促进其身心健康的恢复。最近，康复医疗机构发布了临床实践指南（CPG）和专家共识声明，其中涉及 COVID-19 康复评估和康复治疗的建议。本系统评价旨在评估指导文件的方法学质量和报告质量，评估建议的异质性，并总结 COVID-19 康复评估和康复治疗的建议，为一线临床医生、治疗师和患者提供快速参考，并为未来的指南提供合理建议。
将检索电子数据库，包括 PubMed、Embase、中国生物医学文献数据库（CBM）、中国科技期刊数据库（VIP）、万方数据库和中国知网（CNKI）以及政府或组织网站（如国家指南清理中心、指南国际网络、国家卫生和临床卓越研究所、苏格兰校际指南网络和世界卫生组织），以获取 2022 年 8 月之前发表的符合条件的 CPG 和专家共识声明。纳入的 CPG 和专家共识声明应为中文或英文，提出的建议应针对现代功能康复技术和/或中医药康复技术在 COVID-19 中的应用。排除综述、解释、CPG 和专家共识声明的旧版本以及大流行期间用于管理其他疾病的版本。两名评审员将独立审查每篇文章，提取数据，根据评估研究和评价 II 工具评估方法学质量，并根据医疗保健实践指南报告项目评估报告质量。将使用一致性评分量表评估不同 CPG 和专家共识声明中建议的异质性。使用组内相关系数计算评审员之间的一致性。我们还将总结 COVID-19 患者康复的建议。结果将以叙述的方式描述，并以表格或图形呈现。
由于本系统评价将使用已发表文献中的信息，因此不需要伦理批准。研究结果将提交给同行评议期刊发表，并按照系统评价和荟萃分析的首选报告项目进行报告。
PROSPERO 注册号：CRD42020190761。
